[Department of Error] Department of Error
Russell S, Bennet J, Wellman JA, et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet 2017; 390: 849–60—In this Article (published Online First on July 13, 2017), the affiliation for Francesca Simonelli should have been Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania Luigi Vanvitelli, Naples, Italy. This correction has been made to the online version as of Aug 24, 2017, and the printed version is correct.